0 NYSE Companies - February 5, 2024Brookfield Announces $10 Billion First Closing for Second Brookfield Global Transition FundWorld’s largest private fund dedicated to investing in the net zero economy On track to exceed previous transition fund size […]Read More
0 NYSE Companies - February 5, 2024The Macerich Company Announces CEO ChangeTom O’Hern to Retire as Chief Executive Officer of The Macerich Company Jackson Hsieh Named as Successor SANTA MONICA, Calif., […]Read More
0 NYSE Companies - February 5, 2024Sonoco Announces Uncoated Paperboard (URB) Mill Closure in Sumner, WashingtonHARTSVILLE, S.C., Feb. 05, 2024 (GLOBE NEWSWIRE) — Sonoco Products Company (“Sonoco” or the “Company”) (NYSE: SON), one of the largest […]Read More
0 Canadian Stock Exchange News - February 5, 2024Christina Lake Cannabis Announces Acquisition Agreement and FinancingVANCOUVER, British Columbia, Feb. 05, 2024 (GLOBE NEWSWIRE) — Christina Lake Cannabis Corp. (CSE: CLC) (OTCQB: CLCFF) (FRANKFURT:CLB), (the “Company” […]Read More
0 NASDAQ Companies - February 5, 2024Arqit and Carahsoft Partner to Bring Symmetric Key Agreement Cybersecurity Product to the US Public SectorLONDON and RESTON, Va., Feb. 05, 2024 (GLOBE NEWSWIRE) — Arqit Quantum Inc. (Nasdaq: ARQQ, ARQQW) (Arqit), a leader in […]Read More
0 NASDAQ Companies - February 5, 2024BioCryst to Present New ORLADEYO® (berotralstat) Real-world Data at 2024 American Academy of Allergy, Asthma & Immunology Annual MeetingRESEARCH TRIANGLE PARK, N.C. , Feb. 05, 2024 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company […]Read More
0 NASDAQ Companies - February 5, 2024Universal Stainless to Present at TD Cowen’s 45th Annual Aerospace/Defense & Industrials Conference on February 14th– Presentation to be Webcast and Archived – BRIDGEVILLE, Pa., Feb. 05, 2024 (GLOBE NEWSWIRE) — Universal Stainless & Alloy […]Read More
0 NASDAQ Companies - February 5, 2024Lexeo Therapeutics Strengthens Clinical Development Leadership with New Executive AppointmentsNEW YORK, Feb. 05, 2024 (GLOBE NEWSWIRE) — Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated […]Read More
0 NASDAQ Companies - February 5, 2024Achilles Therapeutics to Present at the 10th Annual Immuno-Oncology 360 ConferenceLONDON, Feb. 05, 2024 (GLOBE NEWSWIRE) — Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing AI-powered precision T […]Read More
0 TSX News - February 5, 2024Descartes Sets Date to Announce Fiscal 2024 Fourth Quarter and Year-End Financial ResultsWATERLOO, Ontario and ATLANTA, Feb. 05, 2024 (GLOBE NEWSWIRE) — Descartes Systems Group (TSX: DSG) (Nasdaq: DSGX), the global leader […]Read More